You are viewing the site in preview mode

Skip to main content


We're creating a new version of this page. See preview

  • Poster presentation
  • Open Access

Acute unilateral vestibular loss as onset of zoster oticus infection

BMC Infectious Diseases201414 (Suppl 7) :P88

  • Published:


  • Hearing Loss
  • Herpes Simplex
  • Herpes Zoster
  • Cortisone
  • Facial Palsy


Objectives: To emphasise the importance of possible aetiologies of unilateral vestibular loss for the long term improvement of quality of life in these patients.

Case report

A 53-year-old man presented at the emergency room with severe vertigo, vomiting and disequilibrium. Based on bed-side otoneurological evaluation and audiometry, we considered a case of vestibular neuritis (usually herpes simplex infection) and we immediately started intravenous treatment with cortisone, vestibular suppressants and betahistine.

Unfortunately, after two days, patient developed ipsilateral peripheral facial palsy, ipsilateral sensorineural severe hearing loss and hyperglycaemia. Patient was included in an antidiabetes treatment protocol. We considered at that later moment the infection as a herpes zoster infection (herpes zoster oticus or auricular herpes zoster, Ramsay Hunt syndrome) and we continued intravenous administration of vasodilators and group B vitamins, but without cortisone due to hyperglycaemia.

Facial palsy recovered slowly but completely as well as dizziness (4 month), but this was not the case with the hearing loss.


Even though recommended treatment for vestibular neuritis is based on cortisone, we always have to keep in mind that the aetiology of the acute unilateral vestibular loss can make the difference in long term recovery of these patients, as well as possible risk of developing iatrogenic hyperglycaemia.


Authors’ Affiliations

Institute of Phono-Audiology and ENT Functional Surgery, Bucharest, Romania
Carol Davila University of Medicine and Pharmacy, Bucharest, Romania


© Georgescu; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.